Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.36 |
| ▸ | RARB | P10826 | 2/20 | 0.33 |
| ▸ | RARG | P13631 | 2/20 | 0.33 |
| ▸ | RARA | P10276 | 1/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.31 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.31 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.31 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.30 |
| ▸ | RXRA | P19793 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24156279 | 0.97 | PDK2 (0.35) | PDK2RARBRARGTDP2RXRA | |
| SCHEMBL24156387 | 0.97 | PDK2 (0.35) | PDK2RARBRARGTDP2RXRA | |
| SCHEMBL18998381 | 0.96 | PDK2 (0.38) | PDK2RARBRARGRARATDP2 | |
| SCHEMBL22182398 | 0.95 | PDK2 (0.36) | PDK2RARBRARGRARATDP2 | |
| SCHEMBL26279065 | 0.94 | PDK2 (0.39) | PDK2 | |
| SCHEMBL26285596 | 0.94 | PDK2 (0.39) | PDK2 | |
| SCHEMBL26279009 | 0.94 | PDK2 (0.39) | PDK2 | |
| SCHEMBL22182385 | 0.93 | RARB (0.36) | PDK2RARBRARGRXRA | |
| SCHEMBL24155971 | 0.93 | PDK2 (0.32) | PDK2RARBRARGRXRA | |
| SCHEMBL22182397 | 0.93 | PDK2 (0.33) | PDK2RARBRARGRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210408381-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | LT MATERIALS CO., LTD. (KR) | 2021-12-30 | — | — | US | disclosed |
| WO-2020138837-A1 | COMPOSITION, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | 엘티소재주식회사 | 2020-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210408381-A1 | COMPOUND, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | OXER1, OR10J3, OR51E2 | PDK2 2490/4885RARB 377/4885RARG 897/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.